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Summary
 
Dendritic cells, but not macrophages, efficiently phagocytose apoptotic cells and cross-present
viral, tumor, and self-antigens to CD8
 
1
 
 T cells. This in vitro pathway corresponds to the in
vivo phenomena of cross-priming and cross-tolerance. Here, we demonstrate that phagocytosis
of apoptotic cells is restricted to the immature stage of dendritic cell (DC) development, and
that this process is accompanied by the expression of a unique profile of receptors, in particular
the 
 
a
 
v
 
b
 
5
 
 integrin and CD36. Upon maturation, these receptors and, in turn, the phagocytic ca-
pacity of DCs, are downmodulated. Macrophages engulf apoptotic cells more efficiently than
DCs, and although they express many receptors that mediate this uptake, they lack the 
 
a
 
v
 
b
 
5
 
 in-
tegrin. Furthermore, in contrast to DCs, macrophages fail to cross-present antigenic material
contained within the engulfed apoptotic cells. Thus, DCs use unique pathways for the phago-
cytosis, processing, and presentation of antigen derived from apoptotic cells on class I major
histocompatibility complex. We suggest that the 
 
a
 
v
 
b
 
5
 
 integrin plays a critical role in the traf-
ficking of exogenous antigen by immature DCs in this cross-priming pathway.
Key words: dendritic cells • phagocytosis • CD36 • integrins • cross-presentation
poptosis triggers a distinct sequence of events charac-
terized by the expression of phosphatidylserine (PS)
 
1
 
on the cell surface (1), DNA fragmentation or laddering
(2), and the release of membrane-bound cell fragments
called apoptotic blebs and bodies (3, 4). Apoptotic cells and
bodies are phagocytosed via various receptors that recog-
nize PS and other undefined ligands unique to the surface
of apoptotic material (1). In this way, dying cells, which
contain potentially inflammatory factors, are rapidly cleared
by neighboring cells, scavenger cells, or macrophages with-
out inducing an inflammatory response (5, 6).
We have recently demonstrated that human dendritic cells
(DCs) acquire antigens from apoptotic cells and stimulate an-
tigen-specific class I–restricted CD8
 
1
 
 T cells (7). Apoptotic
death is a critical trigger for this pathway, as antigen from
necrotic cells is not presented on MHC I (7). This in vitro
model for cross-priming may be akin to the in vivo pheno-
menon in which antigens derived from MHC-mismatched
donor cells are cross-presented on host APC’s class I MHC
(8–10). This event is potentially significant in the main-
tenance of tolerance to tissue-specific antigens and the in-
duction of immunity to antigens that may not access the
endogenous MHC class I pathway of a professional APC.
Here, we investigate the developmental stage and recep-
tors used by DCs for the efficient phagocytosis of apoptotic
cells in this exogenous pathway. DCs undergo a differentia-
tion process that includes ‘immature’ and ‘mature’ stages
(11). Monocytes that have been cultured in GM-CSF and
IL-4 develop into immature DCs. These cells are analogous
to peripheral tissue DCs. Immature DCs are characterized by
high endocytic and macropinocytic activity (12–16) and low
expression of accessory signals for T cell activation (11, 17).
Maturation of DCs, induced by antigen, cytokines, or signal-
ing molecules (e.g., LPS, monocyte-conditioned medium
[MCM], ceramide, CD40L, TNF-
 
a
 
, and PGE2 [12, 13, 18–
22]) is associated with the downregulation of antigen uptake,
but an enhancement of the T cell stimulatory capacity. By
using a modified FACS
 
Ò
 
-based method for detecting phago-
cytic uptake, we compared immature DCs, mature DCs, and
macrophages for their capacity to phagocytose apoptotic cells
and cross-present viral antigens to CTLs (23). We report that
immature DCs are specialized in their ability to cross-present
antigen and that the phagocytosis of apoptotic cells correlates
with the use of a unique receptor profile.
 
1
 
Abbreviations used in this paper:
 
 Ann V, Annexin V; DC, dendritic cell;
MCM, monocyte-conditioned medium; PI, propidium iodide; PS, phos-
phatidylserine.
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Materials and Methods
 
Media.
 
RPMI 1640 supplemented with 20 
 
m
 
g/ml of gen-
tamicin (GIBCO BRL, Gaithersburg, MD), 10 mM Hepes (Media-
tech, Herndon, VA), and either 1% human plasma, 5% pooled
human serum (c-Six Diagnostics, Mequon, WI), or 5% single donor
human serum was used for DC preparation, cell isolation, and cul-
ture conditions (18, 24).
 
Preparation of Cells.
 
PBMCs, DCs, macrophages, and T cells
were prepared as previously described (18, 19, 24). In brief, pe-
ripheral blood was obtained from normal donors in heparinized
syringes and PBMCs were isolated by sedimentation over Ficoll-
Hypaque (Amersham Pharmacia Biotech, Piscataway, NJ). T
cell–enriched and T cell–depleted fractions were prepared by ro-
setting with neuraminidase-treated sheep red blood cells (24). Im-
mature DCs were prepared from the T cell–depleted fraction by
culturing cells in the presence of GM-CSF and IL-4 for 7 d.
1,000 U/ml of GM-CSF (Immunex Corp., Seattle, WA) and
500–1,000 U/ml of IL-4 (Schering-Plough Corp., Kenilworth,
NJ) were added to the cultures on days 0, 2, and 4. To generate
mature DCs, the cultures were transferred to fresh wells on day 7
and MCM was added for an additional 3–4 d (18, 19). At day 7,
 
.
 
95% of the cells were CD14
 
2
 
CD83
 
2
 
HLA-DR
 
lo
 
 DCs. On days
10–11, 80–100% of the cells were of the mature CD14
 
2
 
CD83
 
1
 
HLA-DR
 
hi
 
 phenotype. FACSort
 
Ò
 
 (Becton Dickinson, San Jose,
CA) was used to generate highly pure populations of immature
and mature DCs, based on their CD83
 
2
 
 and CD83
 
1
 
 phenotypes,
respectively. Macrophages were isolated from T cell–depleted
fractions by plastic adherence for 1 h. After 24 h, cells were re-
moved from the plates and placed in Teflon beakers for 3–9 d. T
cells were further purified from the T cell–enriched fraction by
removing contaminating monocytes, NK cells, and B cells (24).
 
Antibodies.
 
Antibodies to the following proteins were used:
CD8-PE, CD14-PE, HLA-DR–PE, HLA-DR–biotin (Becton
Dickinson), IgG2b (clone 6603001; Coulter Corp., Hialeah, FL),
CD8 (CRL 8014; American Type Culture Collection, Rock-
ville, MD), CD83 (clone HB15a; Coulter Corp.), MHC I (W6/
32, ATCC clone HB95), CD36 (clone FA6; obtained from the
fifth international workshop on leukocyte differentiation antigens),
 
a
 
v
 
 (clone CLB-706, Chemicon International, Inc., Temecula,
CA; clone 69.6.5, Coulter Corp.), 
 
b
 
1
 
 (clone 6S6; Chemicon Inter-
national, Inc.), 
 
b
 
3
 
 (clone SZ21, Coulter Corp.; clone RUU-PL
7F12, Becton Dickinson), 
 
b
 
5
 
 (clone B5-IVF2; Upstate Biotechnol-
ogy, Inc., Lake Placid, NY), 
 
a
 
v
 
b
 
3
 
 (clone 23C6; PharMingen, San
Diego, CA), 
 
a
 
v
 
b
 
5
 
 (clone P1F6; Chemicon International, Inc.),
CD71 (Dako Corp., Carpinteria, CA), mannose receptor (clone
3.2PB1; a gift from A. Lanzavecchia, Basel Institute, Sweden), and
influenza nucleoprotein (ATCC clone HB85).
 
Induction of Apoptotic Death.
 
Monocytes were infected with
influenza virus in serum-free RPMI. These cells undergo viral-
induced apoptotic death within 6–8 h. Cell death was confirmed
using the Early Apoptosis Detection kit (Kayima Biomedical Co.,
Seattle, WA [7]). As previously described, cells are stained with An-
nexin V–FITC (Ann V) and propidium iodide (PI). Early apopto-
sis is defined by Ann V
 
1
 
/PI
 
2
 
 staining as determined by FACS-
can
 
Ò
 
 (Becton Dickinson). To ensure that we were studying the
uptake of early apoptotic cells, the kinetics of death were carefully
worked out. 5–8 h after infection, monocytes first externalize PS
on the outer leaflet of their cell membrane, as detected with Ann
V. By 8–10 h, these cells were TUNEL (Tdt-mediated dUTP-
biotin nick-end labeling) positive. It was not until 24–36 h that
the majority of the monocyte population included trypan blue
into the cytoplasm, an indicator of secondary necrosis (Albert,
M.L., and N. Bhardwaj, unpublished data, references 25, 26).
HeLa cells were triggered to undergo apoptosis using a 60 UVB
lamp (Derma Control Inc.), calibrated to provide 2 mJ/cm
 
2
 
/s. The
kinetics of cell death in these cells has been defined previously (4).
 
Phagocytosis of Apoptotic Cells.
 
Monocytes and HeLa cells were
dyed red using PKH26-GL (Sigma Biosciences, St. Louis, MO),
and induced to undergo apoptosis by influenza infection and UVB
irradiation, respectively. After 6–8 h, allowing time for the cells to
undergo apoptosis, they were cocultured with phagocytic cells that
were dyed green using PKH67-GL (Sigma Biosciences), at a ratio of
1:1. Macrophages were used 3–6 d after isolation from peripheral
blood; immature DCs were used on days 6–7 of culture; and mature
DCs were used on days 10–11. Where direct comparison of cells
was needed, cells were prepared from the same donor on different
days. In blocking experiments, the immature DCs were preincu-
bated in the presence of 50 
 
m
 
g/ml of various mAbs for 30 min
before the establishment of cocultures. After 45–120 min, FACScan
 
Ò
 
analysis was performed and double positive cells were enumerated.
 
Phagocytosis of Latex Beads.
 
Immature DCs were preincu-
bated at 37
 
8
 
C with mAbs specific for 
 
a
 
v
 
 and 
 
a
 
v
 
b
 
5
 
. 10
 
6
 
 cells were
then cultured with 5 
 
3
 
 10
 
7
 
 red fluorescent microspheres (diame-
ter 1 
 
m
 
m, 2.5% solids, carboxylate-modified latex; Sigma Chemi-
cal Co.) for varying periods of time. Alternatively, the cells were
maintained at 4
 
8
 
C. At the end of the assay, cells were separated
from unengulfed beads by density gradient centrifugation and an-
alyzed by FACScan
 
Ò
 
 analysis (27).
 
Immunofluorescence.
 
Cells were adhered to Alcian blue (Sigma
Chemical Co.) treated coverslips and fixed using 100% acetone.
Cells were stained with antiinfluenza nucleoprotein antibody
(HB85; American Type Culture Collection) and Texas red conju-
gated goat anti–mouse IgG (Jackson ImmunoResearch Labs., Inc.,
West Grove, PA). This was followed by staining with biotinylated
anti–HLA-DR (Becton Dickinson) followed by FITC-conjugated
streptavidin (Jackson ImmunoResearch). Cells were visualized using
a Zeiss Axioplan2 microscope (Carl Zeiss, Inc., Thornwood, NY).
 
Assay for Cross-priming of Apoptotic Cells.
 
Various APC popu-
lations were prepared from HLA-A2.1
 
1
 
 donors as described
above. Mature DCs were further purified by labeling with the
DC-restricted marker CD83, followed by cell sorting on the FAC-
Sort
 
Ò
 
. Immature DCs were CD14
 
2
 
 and sorted by FACSort
 
Ò
 
 as a
CD83
 
2
 
 population. Mature macrophages were generated by cul-
turing an adherent mononuclear cell fraction in a Teflon beaker
for 9 d. These APC populations were cocultured with HLA-
A2.1
 
2
 
 influenza-infected monocytes. After 12 h, the APCs were
loaded with Na
 
51
 
CrO
 
4
 
 and used as targets for influenza-specific
CTLs in a standard 
 
51
 
Cr-release assay (7, 24). Specific lysis indi-
cates that the APC had cross-presented antigenic material derived
from the apoptotic cell, leading to the formation of specific pep-
tide–MHC class I complexes on its surface. Specific lysis 
 
5
 
 (%
killing of APCs cross-presenting influenza-infected monocytes) 
 
2
 
 (%
killing of APCs cross-presenting uninfected monocytes). Back-
ground lysis ranged from 0 to 8%. Controls included influenza-
infected and uninfected mature DCs, immature DCs, and macro-
phages. The HLA-A2.1
 
2
 
 monocytes used as a source of apoptotic
material were also tested as targets to demonstrate the absence of
lysis when using a mismatched target. For the control targets, spe-
cific lysis 
 
5
 
 (% killing of influenza-infected APCs) 
 
2
 
 (% killing
of uninfected APCs). Background lysis ranged from 0 to 5%.
Maximal influenza-specific killing was determined using T2 cells
(a TAP
 
2
 
/
 
2
 
HLA-A2.1
 
1
 
 class II
 
2
 
 cell line) pulsed for 1 h with 1
 
m
 
M of the immunodominant influenza matrix peptide, GILG-
FVFTL, as targets (28). Responses varied from 25 to 60% as a
function of the individual’s prior exposure to influenza. 
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Reverse Transcriptase PCR.
 
RNA was purified from highly
purified sorted cell populations of immature and mature DCs as de-
scribed above. Messenger RNA for 
 
b
 
3
 
, 
 
b
 
5
 
, and CD36 were identi-
fied using a one-step reverse transcriptase PCR reaction (Titan kit;
Boehringer Mannheim, Indianapolis, IN). The forward primer
5
 
9
 
-TGAGAAGTGCCCCTGCCC was used for both 
 
b
 
3
 
 and 
 
b
 
5
 
.
The reverse primers 5
 
9
 
-GTTGGCTGTGTCCCATTTTGCT
and 5
 
9
 
-TTGTAGGATTTGTGAACTTG were used for 
 
b
 
3
 
 and
 
b
 
5
 
 to obtain 438- and 509-bp products, respectively (primer se-
quences were provided by S. Silletti, Scripps, San Diego, CA). The
forward primer 5
 
9
 
-GGGAATTCATATGAAATCATAAAAG-
CAACAAACAT and the reverse primer 5
 
9
 
-CGGAATTCTA-
CATTTCACTTCCTCATTTTCTG for CD36 yielded a prod-
uct of 392 bp (29). The reverse transcriptase reaction was carried
out for 30 min at 56
 
8
 
C followed by 30 cycles of amplification. Af-
ter 30 cycles of PCR the samples were visualized on an agarose gel.
 
Results
 
Immature DCs Efficiently Phagocytose Apoptotic Cells.
 
Based
on previous observations that immature DCs are the cells
responsible for capturing antigen (11), we predicted that
apoptotic cells would be engulfed best by immature DCs.
To test this hypothesis, we established a phagocytosis assay
that allowed us to visually detect the uptake of apoptotic
cells, and compare the phagocytic capacity of immature
DCs, mature DCs, and macrophages. In brief, immature
DCs were prepared by culturing a T cell–depleted fraction
from peripheral blood in the presence of IL-4 and GM-CSF.
Mature DCs were generated with the addition of MCM
and these cells expressed the cell surface DC-restricted
maturation marker CD83 (18, 19, 30). Macrophages were
prepared by culturing a plastic adherent cell population in
Teflon beakers for 3–9 d. As a source of apoptotic cells, we
used influenza-infected monocytes (7); virus infection in-
duces apoptotic death in these cells within 6–10 h (7, 25,
26). Monocytes were first infected with influenza virus as
Figure 1. Immature but not ma-
ture DCs efficiently phagocytose
apoptotic cells. Freshly isolated
blood monocytes were infected
with live influenza A, PR/8
(Spafas Inc., Storrs, CT), labeled
with the PKH26-GL fluorescent
cell linker compound (Sigma Bio-
sciences), and incubated at 378C
for 6–8 h, allowing apoptosis to
occur. Macrophages, immature
DCs, and mature DCs were dyed
with PKH67-GL and added to the
culture wells containing the apop-
totic monocytes at a ratio of 1:1.
Cells were analyzed by FACScanÒ where double positive cells indicate
uptake of the apoptotic cells by the various APCs (iii, vi, and ix). We used
the various APCs alone to establish the proper settings (i, iv, and vii). Note
that as the forward scatter of the APCs increased, the dying monocytes
were excluded from the established region (ii, v, and viii). After 2 h, 80%
of the macrophages, 50% of the immature DCs, and ,10% of the mature
DCs had engulfed the apoptotic monocytes (A). In an independent ex-
periment, macrophages (squares), immature DCs (diamonds), and mature
DCs (circles) were prepared, and cocultures with apoptotic monocytes
were established as described above. FACSÒ was performed at various
time points. Percentage of phagocytosis was calculated based on the num-
ber of double positive cells (B).
Figure 2. Low temperature, Cytochalasin
D, and EDTA block phagocytosis of apop-
totic cells by immature DCs. Apoptotic
monocytes and immature DCs were pre-
pared as described above. Immature DCs
were preincubated at 48C (A) in the pres-
ence of varying concentrations of Cytocha-
lasin D (B) or EDTA (C) for 30 min. Apop-
totic monocytes were then added to the DC
cultures at 48C (A) or 378C (B and C).
FACSÒ analysis was performed after 1–2 h.
Data shown are representative of five inde-
pendent experiments in which influenza-
infected monocytes or UVB-irradiated HeLa
cells were sources of apoptotic food for the
immature DCs. Percentages of inhibition
6 SD for these experiments were: 48C, 85
6 7%; 10 mM Cytochalasin D, 69 6 3%;
and 2 mM EDTA, 76 6 14%.1362 Immature DCs Engulf Apoptotic Cells; A Novel Role for the avb5 Integrin
previously described (24), then dyed red using PKH-26
(Sigma Biosciences). After 6–8 h, the various APCs were
dyed green using the fluorescent cell linker compound
PKH67-GL (Sigma Biosciences) and cocultured with the
apoptotic cells at a ratio of 1:1. After 2 h at 378C, cocul-
tures of cells were analyzed by FACScanÒ analysis, allowing
for quantification of phagocytic uptake as double positive
cells. 80% of the macrophages, 50% of the immature DCs,
and  ,10% of the mature DCs engulfed the apoptotic
monocytes after 2 h of coculture (Fig. 1 A). The smear of
double positive cells (PKH67-labeled APCs that engulfed
the PKH26-labeled apoptotic cells) indicates that both apop-
totic bodies and whole apoptotic cells served as ‘food’ for
the phagocytic cell (Fig. 1, iii, vi, and ix). Note that as the
forward scatter of the APCs increased and the setting of the
FACSÒ shifted, the dying monocytes were excluded from
the established region (Fig. 1, ii, v, and viii). Maximal uptake
by all APC populations was achieved within 2–4 h and par-
tially depended upon the source of apoptotic cell used (Fig.
1 B and data not shown). Given this kinetic data, we believe
that macrophages and DCs engage and internalize dying
cells while still displaying features of early apoptotic cell
death. This data also demonstrates that it is the immature
DC that preferentially acquires apoptotic material compared
with the mature DC. The source of apoptotic cells was not
critical, since we obtained similar results with UVB-irradi-
ated HeLa cells (see Fig. 7, and data not shown).
To confirm that this FACSÒ assay was measuring phago-
cytosis, we carried out the assay at 48C and in the presence
of inhibitors of phagocytosis. Both low temperature (Fig.
2 A) and cytochalasin D, an inhibitor of cytoskeletal func-
tion, blocked uptake (Fig. 2 B). Phagocytosis by immature
DCs also requires divalent cations as EDTA was inhibitory
(Fig. 2 C). To visually confirm the uptake recorded by
FACSÒ, we prepared cytospins of the dyed cocultures. The
frequency of uptake correlated with that measured on
FACSÒ (data not shown). We also performed immunofluo-
rescence on cocultures of immature DCs labeled with anti–
HLA-DR (DR) and apoptotic influenza-infected monocytes
labeled with antiinfluenza nucleoprotein (NP) (Fig. 3). In
the top panel an apoptotic cell is seen just prior to being
engulfed by a DC (arrowhead). After phagocytosis, apoptotic
cells were found in DR1 vesicles (arrows), but not in the
cytoplasm.
Only Immature DCs Cross-present Antigen from the Apoptotic
Cell on Class I MHC. We next correlated the phagocytic
capability of macrophages and DCs with their ability to
cross-present antigenic material derived from apoptotic
cells. The cells were prepared from HLA-A2.11 donors
(18, 19), cocultured with HLA-A2.12 influenza-infected
monocytes for 12 h, and then loaded with Na51CrO4 for
use as targets for influenza-specific CTLs (7, 24). Specific
lysis indicates that the APCs cross-presented antigenic ma-
terial derived from the apoptotic cell by forming specific
peptide–MHC class I complexes on its surface (Fig. 4 A).
As a direct comparison with the endogenous pathway for
class I MHC presentation, the same APC populations were
infected with live influenza virus and used as targets (Fig. 4 B).
Although mature DCs were efficient targets when infected
with influenza, they were unable to cross-present antigens,
presumably because they had downregulated the ability to
phagocytose the apoptotic monocytes. However, the imma-
ture DCs did cross-present antigens from apoptotic cells. Fur-
thermore, if the immature DCs were cocultured with the
apoptotic cells in the presence of MCM, a maturation stimulus,
they were even better targets. This is possibly due to the
upregulation of costimulator and adhesion molecules (13, 31),
or to the increased stability of peptide–MHC I complexes.
Given that maximal uptake of apoptotic cells by immature
DCs occurs between 2 and 4 h (Fig. 1 D), we believe that
cross-presentation of apoptotic material reflects the phagocyto-
sis and processing of early apoptotic cells rather than secondary
necrotic cells (see Materials and Methods). With respect to this
issue, it is important to recognize that the influenza-infected
monocytes require 24 h to undergo secondary necrosis (Albert,
M.L., and N. Bhardwaj, unpublished data; references 25, 26).
Figure 3. Immature DCs engulf influenza-infected monocytes. Influ-
enza-infected apoptotic monocytes were cocultured with immature DCs
for 1 h, after which the cells were adhered to a coverslip and fixed with
acetone. Immunofluorescence was performed with antiinfluenza nucle-
oprotein antibodies (NP) and Texas red–conjugated goat anti–mouse IgG
and by biotinylated anti–HLA-DR (DR) followed by FITC-conjugated
streptavidin. The large arrowhead indicates apoptotic cell outside the DC
before engulfment. Small arrows indicate apoptotic material derived from
the influenza-infected monocytes within DR1 vesicles of the DC. These
images were not generated on a confocal scope, so the structures of the
DC underlying the apoptotic cell can be seen.1363 Albert et al.
Notably, macrophages that efficiently phagocytose apop-
totic cells (Fig. 1 A) did not cross-present antigens to CTLs
(Fig. 4 B). Presumably, the engulfed material is degraded,
not cross-presented, on MHC I. This profound difference
between the DC and macrophage populations is supported
by our previous findings that macrophages do not cross-
present antigens from apoptotic cells during the induction
phase of a class I–restricted antigen-specific T cell response.
In fact, when put into culture with DCs in a competition
assay, they sequester the apoptotic material and abrogate
the CTL response (7).
Immature DCs Can Be Distinguished from Macrophages by
Intracellular Expression of CD83 and a Unique Profile of Phago-
cytic Receptors. We investigated the possibility that imma-
ture DCs might phagocytose apoptotic cells via pathways
distinct from macrophages. To clearly distinguish these
cells, we characterized them phenotypically. Immature DCs
are distinguished by the absence of both CD14, a macro-
phage restricted marker, and CD83, a maturation marker
for DCs (30). We have extended the use of CD83, finding
that immature DCs can be distinguished from both macro-
phages and mature DCs by their intracellular expression of
CD83. Macrophages do not express CD83 intra- or extra-
cellularly, whereas mature DCs express CD83 both intra-
and extracellularly (Fig. 5).
These APC populations were examined for surface ex-
pression of receptors involved in phagocytosing apoptotic
material (Table 1). These include: avb3 and CD36, which
act as coreceptors for engulfment of apoptotic neutrophils
and lymphocytes by macrophages (32, 33); and CD14,
which has been implicated in the uptake of apoptotic cells
by macrophages (34). While studying the immature DC
populations, we identified a discrepancy in the expression
of the av and b3 integrin chains and investigated the possi-
bility that av was binding an alternate b chain. Using anti-
bodies that recognize combined epitopes of the avb3 and
the avb5 heterodimers, we noted the selective expression of
avb5 on immature DCs (Fig. 6 A). As is true for most
receptors involved in antigen uptake (11, 12), the expres-
sion of CD36, avb5, and mannose receptor on DCs is
downregulated with maturation (Fig. 6 B, Table 1).
To evaluate whether this downregulation could be ob-
served on the level of mRNA expression, we performed
reverse transcriptase PCR using primers specific for b3, b5,
and CD36 (Fig. 6 C). Immature DCs (lane 1) showed am-
plified DNA of the appropriate size for b3, b5, and CD36.
In contrast, in mature DCs (lane 2), no b5 and much fewer
CD36 sequences were seen, whereas b3 sequences were
comparable to those in immature cells. These data, al-
though not quantitative, are consistent with the levels of
protein expression observed by FACSÒ and suggest that
phagocytic receptor expression in DCs may be regulated at
a transcriptional level as mRNA expression of CD36 and
b5 is downregulated during maturation.
avb5 and CD36 Mediate Phagocytosis of Apoptotic Cells in
Immature DCs. To demonstrate a direct role for avb5 in
the recognition of apoptotic cells by immature DCs, we
performed the phagocytosis FACSÒ assay in the presence of
Figure 4. Immature DCs but not mature DCs or macrophages cross-
present antigenic material derived from apoptotic cells. Various popula-
tions of HLA-A2.11 APCs were cocultured with HLA-A2.12 influenza-
infected monocytes. After 12 h, the APCs were loaded with 51Cr and
used as targets for HLA-A2.11 influenza-reactive CTL lines. Mature DCs
were isolated by labeling with the DC-restricted marker CD83, followed
by cell sorting on the FACSortÒ. Immature DCs were CD142 and were
sorted by FACSortÒ as a CD832 population. Mature macrophages were
generated by culturing an adherent mononuclear cell fraction in a Teflon
beaker for 9 d. Effector/target ratios 5 45:1 and 15:1 (A). Controls in-
cluded infected and uninfected mature DCs, immature DCs, and mac-
rophages. The HLA-A2.12 monocytes used as a source of apoptotic ma-
terial were also tested as targets to demonstrate the absence of lysis when
using a mismatched target. Effector/target ratios 5 45:1 and 15:1. Results
are representative of three experiments and the values shown represent
the mean of triplicate wells (B).
Figure 5. Intracellular but not extracellular CD83 expression distin-
guishes immature DCs from mature DCs and macrophages. Macro-
phages, immature DCs, and mature DCs were prepared as previously de-
scribed. Cells were either untreated (Surface) or permeabilized with
saponin (Intracellular), and incubated with anti-CD83. Cells were then la-
beled using a PE-conjugated GAM-Ig (Sigma Biosciences). An isotype-
matched antibody was used (IgG2a) as a control.1364 Immature DCs Engulf Apoptotic Cells; A Novel Role for the avb5 Integrin
antibodies specific for avb5 (Fig. 7 A). In addition to the
blocking observed using the mAb to avb5, blocking was
also detected when using mAbs to av, b5, and CD36.
Blocking was not observed when isotype-matched mAbs
were specific for b1, b3, or the transferrin receptor CD71.
Note that control antibodies chosen recognized surface re-
ceptors present on the immature DCs (Fig. 7 A, Table 1).
mAbs were tested in doses ranging from 10 to 80 mg/ml
(data not shown). Maximal inhibition of phagocytosis of
apoptotic cells was seen with mAbs specific for CD36, av,
and b5 at 50 mg/ml. The inhibition of phagocytosis of apop-
totic cells by DCs was specific. We were unable to block
the uptake of red fluorescent latex beads, a control particle,
by DCs in the presence of these mAbs (Fig. 7 B). By histo-
gram analysis, DCs phagocytose 1–6 particles per cell.
mAbs to avb5 or av did not alter the profile of these histo-
gram plots (data not shown).
Although some inhibition of phagocytosis was observed
when using avb3 this may be due in part to transdominance
and/or the effect on the pool of free av (35). For example,
anti-avb3 antibodies suppress the intracellular signaling of
the a5b1 integrin (36). Alternatively, avb3 and avb5 may be
working cooperatively in the immature DCs. We therefore
tested combinations of anti-avb3 and anti-avb5 but did not
observe an increase in the inhibition of phagocytosis. The
low receptor density of avb3 on DCs (average mean fluo-
rescence intensity of 7 6 2; Table 1) also makes it unlikely
that this integrin heterodimer is involved in the engulfment
of apoptotic cells by immature DCs.
Our data do not exclude a role for other receptors in the
phagocytosis of apoptotic cells, e.g., the putative PS recep-
tor or the lectin receptor (5). In fact, other receptors are
probably involved, as blocking observed did not exceed
60% even when combinations of all relevant mAbs were
tested (data not shown). CD14 is unlikely to be involved in
the engulfment of apoptotic cells by DCs, as DCs do not
express this receptor (Table 1). In macrophages, phago-
cytosis of apoptotic cells was inhibited by antibodies to av,
b3, avb3, and CD36 but not by antibodies to b1, b5, or
avb5 (data not shown). This correlates with published data
(6, 33).
Discussion
Cross-presentation of antigens to CTLs appears to have
two critical features: (a) it is mediated by DCs, and (b) apop-
totic cells are the preferred source of antigen (7). The req-
uisite stage of DC development for the acquisition of apop-
totic cells is the immature phase. In fact, immature DCs are
four to five times more efficient than mature DCs in phago-
cytosis, a feature that also correlates with their ability to
cross-present antigen. This exogenous pathway for class I
Table 1. Receptor Profile of Various APCs
Immature DCs
Day 7
Mature DCs
Day 11
Monocytes
Day 0
Macrophages
Day 3
Macrophages
Day 9
n 5 7n  5  6n  5  4n  5  5n  5  5
CD8* 0–2 (3 6 1)§ 0–3 (4 6 1) 0–1 (4 6 1) 0–5 (3 6 1) 1–2 (3 6 1)
CD14* 1–10 (4 6 1) 0–6 (4 6 1) 83–97 (149 6 90) 67–98 (61 6 20) 49–90 (68 6 48)
CD83‡ 8–43 (8 6 4) 73–99 (114 6 15) 0–1 (3 6 1) 4–19 (4 6 2) 2–14 (4 6 2)
MHC I‡ 99–100 (311 6 49) 96–100 (280 6 69) 99–100 (99 6 38) 97–99 (164 6 24) 95–100 (116 6 18)
HLA-DR* 88–100 (84 6 35) 98–99 (188 6 40) 94–99 (63 6 9) 97–99 (173 6 34) 5–89 (25 6 27)
CD8‡ 3–9 (4 6 1) 2–8 (3 6 1) 0–2 (3 6 1) 1–4 (3 6 0) 1–5 (3 6 1)
IgG2b‡ 3–7 (3 6 1) 2–7 (3 6 1) 0–2 (3 6 0) 1–4 (3 6 1) 1–5 (3 6 1)
CD36‡ 75–99 (75 6 31) 20–50 (9 6 2) 89–99 (62 6 18) 64–98 (69 6 45) 9–55 (15 6 16)
av (CD51)‡ 45–76 (14 6 3) 11–40 (9 6 3) 2–12 (4 6 1) 2–35 (6 6 2) 18–75 (10 6 5)
b1 (CD29)‡ 99–100 (287 6 57) 84–100 (112 6 28) 95–100 (61 6 33) 83–100 (72 6 23) 68–99 (104 6 29)
b3 (CD61)‡ 14–34 (7 6 2) 10–24 (6 6 1) 76–91 (40 6 16)i 15–85 (14 6 9)i 19–92 (16 6 9)
b5
‡ 78–95 (30 6 8) 32–57 (11 6 2) 6–8 (5 6 1) 8–15 (7 6 2) 5–8 (3 6 1)
avb3 (VnR)‡ 22–28 (7 6 1) 14–30 (7 6 2) 4–8 (4 6 1) 7–27 (5 6 2) 19–68 (10 6 4)
avb5
‡ 81–90 (25 6 5) 12–53 (9 6 3) 1–14 (4 6 1) 0–11 (3 6 1) 6–15 (4 6 1)
CD71‡ 75–99 (50 6 29) 75–94 (61 6 27) 3–7 (4 6 0) 14–30 (7 6 2) 58–81 (30 6 7)
Mannose receptor‡ 99–100 (272 6 68) 38–80 (26 6 11) 2–7 (4 6 0) 24–63 (13 6 8) 48–95 (34 6 20)
*PE-conjugated.
‡Unconjugated antibody.
§Results are expressed as range of values, calculated as percentage of positive cells as compared with an isotype-matched control antibody. Values in
parentheses indicate the average of geometric mean fluorescence intensities of the various samples 6 SD.
iThe b3 expression in the monocytes and day 3 macrophages does not match the avb3 expression due to contaminating platelets that stuck to the
cells during isolation, as determined by staining with anti-CD41 (data not shown).1365 Albert et al.
MHC loading is highly effective: relatively few apoptotic
cells (ratio of 1:10 DCs) are needed to charge the DCs as
efficiently as the live replicating virus; exposure of 3–12 h is
sufficient for generating a peptide–MHC complex that is
capable of activating CTLs; and it is relatively indiscrimi-
nate, as the cellular source can be allogeneic or xenogeneic
cells (7). We believe our earlier studies with mature DCs
are explained by the fact that our cell populations were
asynchronous and that only by sorting these cells have the
differences become apparent. Based on the findings pre-
sented here, we suggest that the peripheral tissue DC, ex-
emplified by the immature DC, has an additional important
role. It is responsible for phagocytosing cells within tissues
that undergo apoptosis (e.g., secondary to viral infection;
during normal cell turnover) and migrating to the draining
lymph nodes where appropriate T cells are engaged. This
pathway may be used for stimulating or tolerizing CTLs
and can account for the in vivo observations of cross-prim-
ing of tumor and viral antigens (9, 37) and cross-tolerance
of self-proteins (10, 38) in their requirement for a bone
marrow–derived APC.
A sharp distinction was also demonstrated between im-
mature DCs and macrophages in the handling of apoptotic
material. Although macrophages are more efficient at phago-
cytosing apoptotic cells than immature DCs, they fail to in-
duce virus-specific CTLs (7). In fact, they cannot even
generate effective levels of peptide–MHC I complexes. In a
short-term assay, influenza-specific CTLs could not kill
macrophages cocultured with apoptotic cells. Therefore,
macrophages degrade rather than cross-present the ingested
apoptotic cells. Our findings probably do not conflict with
the report of Bellone et al. (39), as their ‘macrophages’
were prepared from bone marrow–derived precursors by cul-
turing the cells in GM-CSF for 7 d. This method is tradi-
Figure 6. Protein and mRNA expression of avb5 and CD36 are downregulated during DC maturation. Immature DCs (A) and mature DCs (B) were
incubated with anti-avb3 (clone 23C6; PharMingen), anti-CD36 (clone FA6; obtained from the fifth international workshop on leukocyte differentiation
antigens), or anti-avb5 (clone P1F6; Chemicon International, Inc.), followed by PE-conjugated GAM-Ig (Sigma Biosciences). All cells were analyzed by
FACScanÒ. (C) RNA was isolated from highly purified sorted cell populations of immature and mature DCs as previously described. Reverse transcrip-
tion was carried out and after 30 cycles of PCR the distinct bands for b3, b5, and CD36 could be seen in the immature DCs (lane 1). In mature DCs, only
a faint band for CD36 and no band for b5 could be visualized (lane 2), indicating minimal mRNA. In contrast, a band was evident for b3 in the mature
DCs. Note that the doublet for b3 is an artifact in this particular exposure and does not indicate two unique bands (lane 2). As a positive control, extracts
from Bowes melanoma cells, which are known to express b3 and CD36 (29), were run (lane 3). As negative control, the Bowes melanoma cells were run
in the absence of a reverse transcriptase (lane 4).
Figure 7. Direct inhibition of phagocytosis by anti-avb5 and anti-CD36
antibodies. HeLa cells were labeled with PKH26-GL, followed by irradi-
ation using a 60 UVB lamp (Derma Control Inc.), calibrated to provide
240 mJ cm22 in 2 min, sufficient for the induction of apoptosis. After 6–8 h,
immature DCs dyed with PKH67-GL and pretreated with 50 mg/ml of
various mAbs for 30 min were added to the wells containing apoptotic
HeLa cells. 45–60 min later, cells were analyzed by FACSÒ for double
positive cells. Phagocytic uptake is reported as a percentage of untreated
cells. Maximal phagocytosis ranged from 44 to 52%. Results from three
experiments were averaged and means plotted 1 SD. Similar results (data
not shown) were obtained when apoptotic monocytes were used (A). Im-
mature DCs were incubated with red fluorescent latex beads at 378C
(squares), 48C (diamonds), or 378C in the presence of 50 mg/ml anti-avb5
(circles), or anti-av (triangles). The results shown indicate percentage of
phagocytosis over background (B).1366 Immature DCs Engulf Apoptotic Cells; A Novel Role for the avb5 Integrin
tionally used to generate DCs from bone marrow (40). We
believe that contaminating DCs account for the cross-presen-
tation observed in their studies.
Additional evidence exists that macrophages process apop-
totic cells differently from DCs and prevent an immune re-
sponse. Two groups have demonstrated that phagocytosis
of apoptotic cells suppresses a subsequent inflammatory re-
sponse to LPS stimulation. The macrophage’s cytokine
profile is skewed toward the synthesis of IL-10, IL-13, and
TGF-b, whereas the production of proinflammatory cy-
tokines such as TNF-a, IL-1b, and IL-12 is downmodu-
lated (41, 42). Therefore, the resolution of inflammation is
dependent on at least two pathways for removal of apop-
totic cells: via (a) macrophages, which subvert and suppress
proinflammatory responses, and (b) DCs, which stimulate
T cell responses that clear pathogens responsible for the in-
duction of the apoptotic death.
The avb5 integrin receptor may be pivotal in the distinc-
tive handling of apoptotic cells by immature DCs versus
macrophages, in that its expression is restricted to the
former. We suggest that the unique profile of receptors ex-
pressed by immature DCs affects trafficking of phagocy-
tosed apoptotic cells, and consequently facilitates cross-pre-
sentation. We have previously shown that NH4Cl inhibits
the ability of DCs to process antigen derived from apop-
totic cells, suggesting that processing in an acidic vesicle
(e.g., CIIVs or MIICs) is required (7). Indeed, class I MHC
may interact with processed antigens in such a compart-
ment, as MHC I molecules have been described in associa-
tion with invariant chain (43) and can recycle from the cell
surface to class II vesicles (44). Additionally, there may be
as yet undescribed routes whereby antigens within vesicles
can enter the classical endogenous pathway as described re-
cently for antigens derived from the endoplasmic reticulum
(45).
In contrast to our studies, Rubartelli et al. (46) have
shown that immature DCs express high levels of the avb3
integrin but lack CD36. Their observations are hard to rec-
oncile with data that indicates that avb3 and CD36 are both
required for the engulfment of apoptotic cells by macro-
phages (33, 47). Furthermore, although they demonstrated
inhibition of phagocytosis by DCs with anti-av antibodies,
they did not present phagocytosis data relevant to b3 or the
avb3 heterodimer. However, it is possible that a different
process is being studied, as phagocytosis in their hands is
dependent on late stage Ann V1/PI1 apoptotic cells. Here,
we discuss data relevant to the phagocytosis of early apop-
totic cells with intact plasma membranes.
avb5 and avb3 have both been described as important in
angiogenesis, cell adhesion, migration, and now in their
ability to phagocytose apoptotic cells. avb3 is critical in the
phagocytosis of apoptotic cells in macrophages, where it
acts in a cooperative way with CD36 and thrombospondin,
collectively forming a ‘molecular bridge’ (47). Recently, it
was reported that avb5 but not avb3 is critical for the en-
gulfment of rod outer segments by CD361 retinal pigment
epithelial cells (48, 49). This phagocytic system is also in-
hibited by anti-CD36 antibodies, suggesting that avb5, like
avb3, might cooperate with CD36. Taken together with
our observations, thrombospondin, or possibly other solu-
ble factors, may serve to bridge CD36, avb5, and the apop-
totic cell.
Although similarities in function exist, avb5 can be dis-
tinguished from avb3 in its use of various ligands (e.g., vas-
cular endothelial growth factor [VEGF] vs. basic fibroblast
growth factor [bFGF]), by the requirements for activation,
and by the intracellular signaling pathways (e.g., indirect
activation of protein kinase C) (50). Also significant is the
fact that the cytoplasmic domains of the two b chains are
the portions that show the most considerable diversity (51).
Thus, it is possible that the distinct use of the avb5 versus
avb3 integrin receptors might account for the specialized
functions of DCs in the route by which apoptotic material
is trafficked and presented. In other words, differential ex-
pression of avb5 may be responsible for the ability of DCs
to cross-present antigenic material derived from apoptotic
cells, whereas macrophages scavenge and degrade such ma-
terial.
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